Blue Capital’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
Blue Capital's LLY Position: Q3 2026 in Review
Blue Capital reduced its Eli Lilly (LLY) stake by 4.1% in Q3 2026, selling an estimated $150K and leaving 2,980 shares worth $3.45M. The position accounts for 2.15% of the portfolio, ranked #7.
Blue Capital first reported a position in LLY in Q4 2024 and has held it in 7 quarters since. The position peaked at $3.77M in Q4 2025. 4,106 funds tracked by Wall St. Rank hold LLY as of Q3 2026.
- Blue Capital held 2,980 shares of Eli Lilly worth $3.45M as of Q3 2026.
- Blue Capital sold 127 Eli Lilly shares in Q3 2026, an estimated $150K.
- Eli Lilly made up 2.15% of Blue Capital's portfolio in Q3 2026, its #7 holding.
- Blue Capital first reported a position in Eli Lilly in Q4 2024 and has held it in 7 quarters since.
- Blue Capital's Eli Lilly position peaked at $3.77M in Q4 2025.
- 4,106 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2026.
Based on Blue Capital's 13F filing for Q3 2026, filed 13 Oct 2026.